PL4‐AM23‐SN‐30 | Syphilis Seroprevalence and Incidence in Blood Donors from 2020 to 2022, on Behalf of the US TTIMS Program
Galen Conti,Edward P. Notari,Roger Y. Dodd,Rita A. Reik,Debra Kessler,Brian Custer,Marion C. Lanteri,Birhanu Hailu,Hong Yang,Susan L. Stramer
DOI: https://doi.org/10.1111/trf.3_17554
2023-01-01
Transfusion
Abstract:The Transfusion Transmissible Infections Monitoring System (TTIMS) monitors HIV, HBV, and HCV infections along with adding syphilis infections in October 2020. TTIMS includes ~60% of the US blood supply combining all data from four of the largest US blood collection organizations (BCO) to track demographic and infectious disease trends. We present blood donation syphilis prevalence and incidence based on antibody results for the first 2 years of study. Data were compiled from October 2020 to September 2022. Allogeneic, directed, and COVID-19 convalescent plasma donations were included. Syphilis prevalence estimates were calculated for consensus positive (CP) infections (which include screen reactive, confirmed-positive infections based on total antibodies) and active infections (AI; a subset of CPs that are also rapid plasma reagin [RPR] positive). Donations from one BCO were excluded from AI analyses as RPR was not used during the first year of the study. Incidence was calculated for the 2-year period using repeat incident (seroconverting) donors/total person-years (PY). Prevalence and incidence were stratified by sex, age group, race/ethnicity, first-time donation status, blood type, and US Census region overall and by year. Lastly, the odds of having an HIV infection within syphilis CP and AI were compared to those without syphilis. Nearly 14.75 million donations were divided into 7,576,645 from the first year and 7,170,844 from the second (405,801 less). Overall, syphilis prevalence was 28.4/100,000 (PHT) donations. Significantly higher prevalence occurred during the second versus the first year in most demographic groups. The unadjusted odds of a donor having a CP infection were 1.25 (95% confidence interval [CI]: 1.18, 1.33) times higher in the second year compared to the first, and for AI, 1.31 (95% CI: 1.18, 1.44) times higher in the second year compared to the first. Donations from donors who were male, first-time, black, younger (ages 18–39), and in the South Census region had the highest rates. By quarter, both CP and AI prevalence increased from 24.9 PHT to 35.8 PHT donations for CP, and from 8.9 PHT to 17.4 PHT donations for AI (Figure A). CP donors were 520 (95% CI: 391, 691) times more likely to also be HIV CP compared to non-CP donors, and AI donors were 722 (95% CI: 508, >999) times more likely to also be HIV CP compared to non-AI donors. Overall, incidence was 14.8/100,000 PY, with the highest stratified rates observed in male and black donors. There was a marked increase in syphilis prevalence in donations to the TTIMS program from October 2021 to September 2022 versus the same period in 2020. Continued monitoring is necessary to determine if the upward trend continues to mirror increasing national trends in the general population; that is, from 15.9 syphilis infections PHT in 2012 to 51.5 PHT in 2021 (cdc.gov).